Adenoviral Mediated Gene Therapy for Experimental Glioma
Department of Health and Human Services
1 R43 CA67357-01,
Agency Tracking Number:
Solicitation Topic Code:
Small Business Information
540 Avis Drive, Suite A, Ann Arbor, MI, 48108
Socially and Economically Disadvantaged:
AbstractGliomas are the most common primary intracranial brain tumors and are thought to arise as a neoplastransformation of glial cells in the central nervous system. The prognosis for the disease is poor.surgical resection of the tumor followed by radiation or chemotherapy. This application describes analternative treatment strategies. The effectiveness of an adenovirus vector to deliver the herpes sikinase (tk) gene to inhibit selectively tumor cell growth upon receipt of ganciclovir (GCV) will beadenovirus vector will be specifically introduced into the tumor area by stereotactic injection; GCVsystemically. The plan is to optimize growth inhibition by determining the effectiveness of redosingdeveloping long term release of infectious virions into the surrounding environment.
* information listed above is at the time of submission.